Daniel Bernstein is recorded as Analyst at Capital One, Chairman at Bel Fuse Inc (BELFA) since May 27, 2025 and Board Member at Bel Fuse Inc (BELFA) since January 1, 1986. The newest filing on record that lists Daniel Bernstein as Board Member at Bel Fuse Inc (BELFA) is dated April 10, 2026. Bel Fuse Inc reported in an 8-K filed May 28, 2025 that Daniel Bernstein was appointed a full three-year term on the Board expiring at the Company’s 2028 Annual Meeting of Shareholders, effective May 27, 2025. Bel Fuse Inc reported in an 8-K filed May 28, 2025 that Daniel Bernstein was appointed non-executive Chairman of Bel’s Board of Directors, effective May 27, 2025. Bel Fuse Inc reported in an 8-K filed February 7, 2025 that Daniel Bernstein resigned as President and CEO, effective May 27, 2025. Equibles holds 4 filed executive changes naming Daniel Bernstein; each is listed under recent activity with its source filing. Daniel Bernstein has spoken on 7 earnings calls across 4 companies, most recently for Bel Fuse Inc on July 24, 2024. Those appearances were for Bel Fuse Inc (BELFA), Healthcare Realty Trust Inc (HR), Sabra Health Care REIT, Inc. (SBRA) and Welltower Inc. (WELL). Bel Fuse Inc is classified in the Electronic Components industry within the Technology sector. Other companies whose calls Daniel Bernstein spoke on are classified in the Real Estate sector. Other leadership on record at Bel Fuse Inc includes Farouq Tuweiq (CEO and Board Member), Lynn Hutkin (CFO, Chief Accounting Officer and Head of Investor Relations), David J. Valletta (Board Member) and 7 others.
“each of Mr. Tuweiq (the Company’s new President and Chief Executive Officer) and Mr. Bernstein (Bel’s new non-executive Chairman of the Board) was elected by the shareholders at the 2025 Annual Meeting to a full three-year term on the Board expiring at the Company’s 2028 Annual Meeting of Shareholders.”
“(ii) Daniel Bernstein who prior to the Effective Time served as Bel’s President and Chief Executive Officer and as a director of the Company, became non-executive Chairman of Bel’s Board of Directors (the “Board”);”
“Overall, we were pleased with our second quarter results. The collective work of the global team over the past year has resulted in improved margins, even in a challenging top-line environment.”
“Overall, we were pleased with our financial results for this quarter. Our sales came in at $128 million, which was within the forecast range we provided at our last quarter earnings call.”
“We're very pleased to report a strong finish to a record-breaking year at Bel, where we demonstrated that even during a year with a challenging supply chain environment, our team's dedication and hard work has paid off.”
“I have a question here on the CapEx, which seems a little bit elevated in the quarter. Although, I think in your supplemental, you said it would come down to about 6% of NOI, which still seems a little bit higher than what I was modeling and expecting.”
“I wanted to go back to the vaccine mandate. When you say about 80% of the employees are vaccinated, it seems like that's a large number that could potentially be lost if operators mandate.”
